Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations

作者: F. Gregorio , F. Ambrosi , S. Cristallini , P. Filipponi , F. Santeusanio

DOI: 10.1007/BF00571936

关键词:

摘要: The effects of glimepiride, the newest sulphonylureic compound, on pancreatic insulin and glucagon secretion were studied using classical, isolated, perfused rat pancreas model. influence four different environmental glucose conditions (during a glycaemic stimulus with increasing from 5 to 8.33 mM at stable 0, 2.22 levels) glimepiride was also assessed. At pharmacological concentration strongly stimulated beta-cell activity, producing characteristic biphasic release sharp first-phase secretory peak, followed by prolonged sustained second phase. Environmental concentrations markedly influenced extent, but not pattern glimepiride-induced secretion, as hormone dropped significantly when level reduced. Glimepiride failed alpha-cell activity any levels.

参考文章(36)
Geisen K, Special pharmacology of the new sulfonylurea glimepiride. Drug Research. ,vol. 38, pp. 1120- 1130 ,(1988)
Waldhäusl W, Korn A, Lehr Kh, Malerczyk, Badian M, Determination of the absolute bioavailability of glimepiride (HOE 490), a new sulphonylurea. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 30, pp. 481- ,(1992)
G.C. Weir, J.L. Leahy, E. Barras, L.P. Braunstein, Characteristics of Insulin and Glucagon Release from the Perfused Pancreas, Intact Isolated Islets, and Dispersed Islet Cells Hormone Research in Paediatrics. ,vol. 24, pp. 62- 72 ,(1986) , 10.1159/000180540
H Maruyama, A Hisatomi, L Orci, G M Grodsky, R H Unger, Insulin within islets is a physiologic glucagon release inhibitor. Journal of Clinical Investigation. ,vol. 74, pp. 2296- 2299 ,(1984) , 10.1172/JCI111658
G. Marynissen, G. Smets, G. Kl�ppel, L. Gerlache, W. J. Malaisse, Internalization of Glimepiride and Glibenclamide in the Pancreatic B-cell Acta Diabetologica. ,vol. 29, pp. 113- 114 ,(1992) , 10.1007/BF00572555
V. Leclercq-Meyer, A.G. Akkan, J. Marchand, W.J. Malaisse, Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas Biochemical Pharmacology. ,vol. 42, pp. 1634- 1637 ,(1991) , 10.1016/0006-2952(91)90435-8
L. C. Groop, Sulfonylureas in NIDDM Diabetes Care. ,vol. 15, pp. 737- 754 ,(1992) , 10.2337/DIACARE.15.6.737
Franco Gregorio, Franca Ambrosi, Paolo Filipponi, Sonia Cristallini, Fausto Santeusanio, Glucose Modulates the Amount, but not the Kinetics, of Insulin Released by Sulfonylureas Journal of Diabetes and Its Complications. ,vol. 8, pp. 204- 212 ,(1994) , 10.1016/1056-8727(94)90045-0
Günter Müller, Yusuke Satoh, Karl Geisen, Extrapancreatic effects of sulfonylureas — a comparison between glimepiride and conventional sulfonylureas Diabetes Research and Clinical Practice. ,vol. 28, ,(1995) , 10.1016/0168-8227(95)01089-V
G Bolli, P De Feo, G Perriello, S De Cosmo, P Compagnucci, F Santeusanio, P Brunetti, R H Unger, Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. Journal of Clinical Investigation. ,vol. 73, pp. 917- 922 ,(1984) , 10.1172/JCI111315